Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

American Neurological Association Annual Meeting
U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)
Barcelona Pediatric MS and Related Disorders Update Meeting
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a.
DNA strand breakage by peroxidase-activated mitoxantrone.
Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.
ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
SoCal Symposium on Glial-Neuronal Interactions in Health & Disease
Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1 a) products administered intramuscularly in healthy male and female volunteers.
The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research.
Klotho Is a Neuroprotective and Cognition-Enhancing Protein.
Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
LKB1/STRAD promotes axon initiation during neuronal polarization.
Role of regulatory b cells in neuroimmunologic disorders.
Ampyra (dalfampridine)
Iran mass produces MS drug Ziferon
National MS Society: Ralph I. Straus Award
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Effects of a 4-month Ananda Yoga Program on Physical and Mental Health Outcomes for Persons With Multiple Sclerosis.
Autoimmunity in visual loss.
Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.
Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.

Pages